Tosoh Ink is a quarterly electronic publication that provides information on Tosoh products, updates and events.

Sign up to Receive Tosoh Ink +

Tosoh Ink Blog +

Tosoh Ink Issues (pdf)
Tosoh Ink - Volume 3 Issue 3 - October 2011
AIA-900 - New Immunoassay Analyzer from Tosoh Bioscience
HbA1c Testing: The Importance of Being Accurate
New Assay - DHEA-S
TBI Tech Talk
G8 Lot Change

Tosoh Ink - Volume 3 Issue 1 - February 2011
ST AIA-PACK HbA1c Assay on the AIA-360 and AIA-600 II Analyzers
The Importance of Accuracy and Precision for HbA1c Results
Training DVDs Available for the AIA-360, AIA-600 II and G8 Analyzers

Tosoh Ink - Volume 2 Issue 3 - November 2010
Reproductive Immunoassays in IVF Clinics
New AIA-PACK Update
Flag Utility on the G7 and G8 Analyzers
Tech Talk - Regulatory Compliance

Tosoh Ink - Volume 2 Issue 2 - July 2010
AACC Preview
Interferences in Immunoassays
Tech Talk - Contacting Technical Support

Tosoh Ink - Volume 2, Issue 1 - March 2010*

Tosoh Ink - Volume 1 Issue 3 - October 2009
- RBC Folate
- CMV Monitoring
- Beta thalassemia testing
- Tech Talk - Calibration

Tosoh Ink - Volume 1 Issue 2 - July 2009*

Tosoh Ink - Volume 1 Issue 1 - May 2009
- Tosoh Bioscience, Inc. Turns 20
- Beta Thalassemia Mode on G7 
- Tech Talk with Dr. John Murphy
- Upcoming Analytes


*This edition was removed as it contained an article which implied that the Tosoh G8 may have been cleared for the diagnosis of diabetes.

HbA1c results from the Tosoh G8 should be utilized by physicians in the clinical management of diabetes to assess the long-term efficacy of diabetic control. The Tosoh G8 has been cleared by the FDA for diabetes monitoring. At this time there are no HbA1c assays that are cleared by the FDA for diabetes diagnosis.

We apologize for any confusion that the information contained within this edition may have caused.